Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinaseYANG, V. C; BERNSTEIN, H; COONEY, C. L et al.Thrombosis research. 1986, Vol 44, Num 5, pp 599-610, issn 0049-3848Article

Heparin-induced thrombocytopenia and recent advances in its therapyHASSAN, Y; AWAISU, A; AZIZ, N. A et al.Journal of clinical pharmacy and therapeutics (Print). 2007, Vol 32, Num 6, pp 535-544, issn 0269-4727, 10 p.Article

Molecular weight profiling of low molecular weight heparins utilizing a heparinase degraded oligosaccharide mixture as a calibratorJESKE, W; AHMAD AHSAN; JAWED FAREED et al.Thrombosis research. 1993, Vol 70, Num 1, pp 39-50, issn 0049-3848Article

Heparinase production by Bacteroides speciesRILEY, T. V; MEE, B. J.Microbios letters. 1984, Vol 25, Num 99, pp 141-148, issn 0307-5494Article

MINIMAL HEPARIN COFACTOR ACTIVITY IN DISSEMINATED INTRAVASCULAR COAGULATION AND CIRRHOSIS.BRAUNSTEIN KM; EURENIUS K.1976; AMER. J. CLIN. PATHOL.; U.S.A.; DA. 1976; VOL. 66; NO 3; PP. 488-494; BIBL. 21 REF.Article

PREPARATION OF THREE TYPES OF HEPARIN-SEPHAROSE AND THEIR BINDING ACTIVITIES TO THROMBIN AND ANTITHROMBIN IIIFUNAHASHI M; MATSUMOTO I; SENO N et al.1982; ANALYTICAL BIOCHEMISTRY; ISSN 0003-2697; USA; DA. 1982; VOL. 126; NO 2; PP. 414-421; BIBL. 26 REF.Article

Heparin-induced thrombocytopenia : What clinicians need to knowCHONG, Beng H; ISAACS, Arend.Thrombosis and haemostasis. 2009, Vol 101, Num 2, pp 279-283, issn 0340-6245, 5 p.Article

Heparin and low-molecular-weight heparin : Current use of biologicals in thrombosis and haemostasisGRAY, Elaine; MULLOY, Barbara; BARROWCLIFFE, Trevor W et al.Thrombosis and haemostasis. 2008, Vol 99, Num 5, pp 807-818, issn 0340-6245, 12 p.Article

Activation of heparin cofactor II by heparin and dermatan sulfateTOLLEFSEN, D. M.Nouvelle revue française d'hématologie. 1984, Vol 26, Num 4, pp 233-237, issn 0029-4810Article

A CATALYTIC ROLE FOR HEPARIN. EVIDENCE FOR A TERNARY COMPLEX OF HEPARIN COFACTOR THROMBIN AND HEPARINPOMERANTZ MW; OWEN WG.1978; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1978; VOL. 535; NO 1; PP. 66-77; BIBL. 25 REF.Article

Heparin to pentasaccharide and beyond: The end is not in sightMESSMORE, Harry L; WEHRMACHER, William H; COYNE, Erwin et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, pp 81-88, issn 0094-6176, 8 p., SUP1Conference Paper

Objective assessment of heparin requirements for hemodialysis in humansIRELAND, H; LANE, D. A; CURTIS, J. R et al.The Journal of laboratory and clinical medicine. 1984, Vol 103, Num 4, pp 643-652, issn 0022-2143Article

Les nouvelles héparines = New heparinsDJIANE, P.Méditerranée médicale. 1986, Num 357, pp 21-23, issn 0302-9263Article

Réflexions sur les mécanismes d'action thérapeutique d'une héparine de bas poids moléculaire; fraxiparine = A low molecular weight heparin fragment: an overview of its mechanisms of actionVANDENBROEK, M. D; BORDES, B.Journal de pharmacie clinique (Paris). 1986, Vol 5, Num 1, pp 35-46, issn 0291-1981Article

Simplified chromogenic substrate assay for low molecular weight heparinHANDELAND, G.Thrombosis research. 1986, Vol 42, Num 1, pp 105-108, issn 0049-3848Article

Low molecular weight heparin and its clinical use. International Enoxaparin symposium, San Diego, July 1985SAMAMA, M; HEMCKER, H. C.Haemostasis. 1986, Vol 16, Num 2, pp 69-188, issn 0301-0147Conference Proceedings

Turnover study of heparin cofactor II in healthy manSIE, P; DUPOUY, D; PICHON, J et al.Thrombosis and haemostasis. 1985, Vol 54, Num 3, pp 635-638, issn 0340-6245Article

Les héparines = New heparins. Biological and therapeutic aspectsTOBELEM, G; MOLHO, P; BARZU, T et al.Actualités hématologiques. 1984, Vol 18, pp 218-223, issn 0567-8757Article

Les héparines de bas poids moléculaire/Réunion du Groupe d'Etudes sur l'Hémostase et la Thrombose de la Société Française d'Hématologie, Nancy, 21-22 novembre 1987 = Heparins of low molecular weight/meeting of «groupe d'Etudes sur l'hémostase et la thrombose de la Société Française d'Hématologie», Nancy, 21-22 November 1987ALEXANDRE, P; SAMAMA, M.Journal des maladies vasculaires. 1987, Vol 12, pp 55-151, issn 0398-0499, suppl. BConference Proceedings

Etude de la neutralisation in vitro et in vivo d'une fraction de bas poids moléculaire d'héparine CY 216 par la protamine = In vitro and in vivo neutralisation of a low molecular weight heparin fraction (CY 216) by protamine sulfateDOUTREMEPUICH, C; BONINI, F; MASSE, A et al.Annales pharmaceutiques françaises. 1986, Vol 44, Num 1, pp 65-72, issn 0003-4509Article

Héparine de bas poids moléculaire et hémodialyse = Low molecular weight heparin and hemodialysisDIEVAL, J; MORINIERE, P; ROUSSEL, R et al.Angéiologie (Paris). 1986, Vol 38, Num 4, pp 147-156, issn 0003-3049Article

Anticoagulantly active heparin-like molecules from mast cell-deficient miceMARCUM, J. A; MCKENNEY, J. B; GALLI, S. J et al.American journal of physiology. Heart and circulatory physiology. 1986, Vol 19, Num 5, pp H879-H888, issn 0363-6135Article

Heparin: applications and future prospectsQUICK, D; TROWBRIDGE, A. A.Chest. 1985, Vol 88, Num 5, pp 755-757, issn 0012-3692Article

The new understanding of the drug heparinJAQUES, L. B.Chest. 1985, Vol 88, Num 5, pp 751-754, issn 0012-3692Article

What is the potential for overdiagnosis of heparin-induced thrombocytopenia?LO, Gregory K; SIGOUIN, Christopher S; WARKENTIN, Theodore E et al.American journal of hematology. 2007, Vol 82, Num 12, pp 1037-1043, issn 0361-8609, 7 p.Article